Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening (2021)
- Authors:
- USP affiliated authors: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP ; FRANCISCHINI, ISAQUE ANTONIO GALINDO - FCFRP ; SILVA, GUILHERME MARTINS DA - FFCLRP ; GOMES, SUZANE QUINTANA - FFCLRP ; BARCELOS, MARIANA PEGRUCCI - FCFRP
- Unidades: FCFRP; FFCLRP
- DOI: 10.4155/fmc-2021-0025
- Subjects: ANTIVIRAIS; MEDICAMENTO; COVID-19; BANCO DE DADOS; AVALIAÇÃO DE MEDICAMENTOS; ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
- Keywords: Drug repositioning; Ligand-based drug discovery; Main-protease (Mpro); Structure-based drug discovery
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 13, n. 16, p. 1353-1366, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
FEDERICO, Leonardo Bruno et al. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, v. 13, n. 16, p. 1353-1366, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0025. Acesso em: 29 dez. 2025. -
APA
Federico, L. B., Silva, G. M. da, Melim, L. I. da S. H., Gomes, S. Q., Barcelos, M. P., Francischini, I. A. G., & Silva, C. H. T. de P. da. (2021). Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, 13( 16), 1353-1366. doi:10.4155/fmc-2021-0025 -
NLM
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2025 dez. 29 ] Available from: https://doi.org/10.4155/fmc-2021-0025 -
Vancouver
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2025 dez. 29 ] Available from: https://doi.org/10.4155/fmc-2021-0025 - Lead optimization in drug discovery
- Potential colchicine binding site inhibitors unraveled by virtual screening, molecular dynamics and MM/PBSA
- Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
- Key aspects for achieving hits by virtual screening studies
- Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases
- Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius
- Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran
- Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease
- Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study
- Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents
Informações sobre o DOI: 10.4155/fmc-2021-0025 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003143641.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
